School-supervised use of a once-daily inhaled corticosteroid regimen: A cluster randomized trial
The Journal of Allergy and Clinical Immunology Aug 18, 2018
Gerald JK, et al. - In this cluster-randomized trial, researchers assessed if medication adherence and asthma control can be improved via a school-supervised use of a once-daily inhaled corticosteroid regimen (supervised therapy). They performed this study in 20 elementary schools with a disproportionate enrollment of low income Latino students. Schools were purposively selected, matched, and randomized to receive 9-months of supervised therapy with mometasone furoate or usual care. Eligible subjects were English- or Spanish-speaking students with self-reported asthma. Findings revealed that, in this population of Latino students, asthma control was not improved by supervised therapy vs usual care.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries